908 Devices Inc.

MASS

Add to Watchlist

6.900USD

-0.400-5.48%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

908 Devices Inc.'s Score

Industry at a Glance

Industry Ranking

46 / 206

Overall Ranking

126 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

908 Devices Inc. Highlights

StrengthsRisks

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

Growing

The company is in a growing phase, with the latest annual income totaling USD 56.20M.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is -6.80, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 28.68M shares, decreasing 27.84% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 222.10K shares of this stock.

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

11.000

Target Price

+50.68%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of 908 Devices Inc. is 7.51, ranking 69 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 13.38M, representing a year-over-year increase of 13.62%, while its net profit experienced a year-over-year increase of 127.42%.

Score

Industry at a Glance

Previous score

7.51

Change

0



Financials

9.47

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.67

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.25

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.05

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.13

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of 908 Devices Inc. is 8.19, ranking 41 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -6.80, which is -318.18% below the recent high of 14.85 and -685.75% above the recent low of -53.47.

Score

Industry at a Glance

Previous score

8.19

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 46/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of 908 Devices Inc. is 9.50, ranking 4 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 10.00, with a high of 12.00 and a low of 8.00.

Score

Industry at a Glance

Previous score

9.50

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of 908 Devices Inc. is 6.94, ranking 75 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 8.02 and the support level at 6.11, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.29

Change

-0.35

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of 908 Devices Inc. is 7.00, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 75.86%, representing a quarter-over-quarter decrease of 17.84%. The largest institutional shareholder is Catherine Wood, holding a total of 1.95M shares, representing 5.15% of shares outstanding, with 36.32% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

ARCH Venture Partners

5.73M

--

First Light Asset Management, LLC

4.84M

+3.32%

ARK Investment Management LLC

Star Investors

1.99M

+1.65%

BlackRock Institutional Trust Company, N.A.

1.65M

+3.52%

Knopp (Kevin J)

1.34M

+5.79%

Brown (Christopher D)

985.56K

+2.44%

Needham Investment Management L.L.C.

770.00K

+246.85%

Geode Capital Management, L.L.C.

688.57K

+2.45%

First Eagle Investment Management, L.L.C.

Star Investors

623.88K

+3.30%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of 908 Devices Inc. is 3.56, ranking 121 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.57. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

908 Devices Inc.

MASS

7.45 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.68 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.58 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment